The findings revealed a positive correlation between BCAS3 expression and B cells, CD4+ cells, and dendritic cells, while a negative correlation was observed with CD8+ cells and macrophages in the tumor immune cell infiltration of HNSCC patients (p<0.05) (Figure 3A). Here, BCAS3 is linked to neoplasm.